Are microRNAs true sensors of ageing and cellular senescence?
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
All living beings are programmed to death due to aging and age-related processes. Aging is a normal process of every living species. While all cells are inevitably progressing towards death, many disease processes accelerate the aging process, leading to senescence. Pathologies such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, Huntington’s disease, cardiovascular disease, cancer, and skin diseases have been associated with deregulated aging. Healthy aging can delay onset of all age-related diseases. Genetics and epigenetics are reported to play large roles in accelerating and/or delaying the onset of age-related diseases. Cellular mechanisms of aging and age-related diseases are not completely understood. However, recent molecular biology discoveries have revealed that microRNAs (miRNAs) are potential sensors of aging and cellular senescence. Due to miRNAs capability to bind to the 3’ untranslated region (UTR) of mRNA of specific genes, miRNAs can prevent the translation of specific genes. The purpose of our article is to highlight recent advancements in miRNAs and their involvement in cellular changes in aging and senescence. Our article discusses the current understanding of cellular senescence, its interplay with miRNAs regulation, and how they both contribute to disease processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317 · cited 1×
“MiR-146 has even been suggested to act in a negative feedback loop, given that its expression increases as the inflammatory response progresses (Taganov et al., 2006).”
Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019055108 · Cited by 3,294
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 1×
“The shelterin complex, which includes telomeric repeat binding factor 1 and 2 (TRF1 and TRF2), and protection of telomeres 1, and several other proteins, functions to protect from the inappropriate recognition of telomeres by the cell’s DNA repair system (de Lange, 2005).”
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., & Remaley, A. T. (2011) · Nature Cell Biology · doi:10.1038/ncb2210 · Cited by 2,741
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 1×
“In addition to studies with p53 mutations, another study found that restoration of p53 function in p53 mutants led to regression of tumor growth in liver cancer cell lines of mice through the induction of the host’s innate immune system to act on the tumor cells (Xue et al., 2007).”
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010 · cited 2×
“P53, along with similar proteins p16 and p21, has a number of interactions and relationships with miRNAs. miR-34a is upregulated by p53 and may act by binding and deactivating SIRT1, an inhibitor of p53, causing a positive feedback loop (Chang et al., 2007; Yamakuchi et al., 2008).”
Cleavage of Scarecrow-like mRNA Targets Directed by a Class of Arabidopsis miRNA
Llave, C., Xie, Z., Kasschau, K. D., & Carrington, J. C. (2002) · Science · doi:10.1126/science.1076311 · Cited by 1,627 · cited 1×
“By binding to the 3’ untranslated region (UTR) of mRNA of specific genes, miRNAs function to prevent the translation of specific genes (Llave et al., 2002).”
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · cited 1×
“It acts by downregulating expression of LRF, which inhibits p19ARF, a repressor of p53 inhibitor MDM2 (Polisen 10 et al., 2008; Pomerantz et al., 1998).”
Sheedy, F. J., Palsson-McDermott, E., Hennessy, E. J., Martin, C., O'Leary, J. J., Ruan, Q., Johnson, D. S., Chen, Y., & O'Neill, L. A. J. (2010) · Nature Immunology · doi:10.1038/ni.1828 · Cited by 1,005 · cited 2×
“In addition, miR-21 decreases the 11 expression of PDCD4, a known promoter of inflammatory activity (Sheedy et al., 2009). miR-146a, like miR-21, is modulated in response to pro-inflammatory cytokines in the beta cells of the pancreas (Roggli et al., 2010).”
Cellular senescence and tumor suppressor gene p16
Rayess, H., Wang, M. B., & Srivatsan, E. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27316 · Cited by 825 · cited 1×
“Additionally, p16 tumor suppressor can cause senescence by preventing the G1-S phase transition of the cell cycle through inhibition of CDK4/6 activity, leading to net increased activity of the downstream Rb tumor suppressor (Rayess et al., 2012).”
MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?
Sonkoly, E., Wei, T., Janson, P. C. J., Sääf, A., Lundeberg, L., Tengvall-Linder, M., Norstedt, G., Alenius, H., Homey, B., Scheynius, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000610 · Cited by 754 · cited 1×
“Upregulation of miR-203 in psoriatic plaques leads to downregulation of cytokine signaling 3 (SOCS-3), which is involved in inflammatory responses and keratinocyte functions (Sonkoly et al., 2007).”
Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma
Peng, P., Hyder, O., Firoozmand, A., Kneuertz, P., Schulick, R. D., Huang, D., Makary, M., Hirose, K., Edil, B., Choti, M. A., et al. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-1923-5 · Cited by 546
Bhaumik, D., Scott, G. K., Schokrpur, S., Patil, C. K., Orjalo, A. V., Rodier, F., Lithgow, G. J., & Campisi, J. (2009) · Aging · doi:10.18632/aging.100042 · Cited by 500 · cited 3×
“inflammatory cytokines, a characteristic feature of senescent cells in aging (Bai et al., 2011; Bhaumik et al., 2009; Cho et al., 2015; Feng et al., 2012; Quinn and O’Neill, 2011).”
A trio of microRNAs that control Toll-like receptor signalling
Quinn, S. R., & O'Neill, L. A. (2011) · International Immunology · doi:10.1093/intimm/dxr034 · Cited by 314
Evidence That Aging And Amyloid Promote Microglial Cell Senescence
Flanary, B. E., Sammons, N. W., Nguyen, C., Walker, D., & Streit, W. J. (2007) · Rejuvenation Research · doi:10.1089/rej.2006.9096 · Cited by 272 · cited 2×
“The pathogenesis of AD has been associated with the shortening of telomeres in the microglial cells of the brain in the presence of amyloid plaques (Flanary et al., 2007).”
Cheng, T.-L., Wang, Z., Liao, Q., Zhu, Y., Zhou, W.-H., Xu, W., & Qiu, Z. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.01.032 · Cited by 270 · cited 2×
“An example of downregulation of the Drosha complex comes when methyl-CpG binding protein 2 (MeCP2) binds to the Drosha complex subunit DiGeorge syndrome critical region 8 (DGCR8) protein, preventing effective assembly of the Drosha complex (Cheng et al., 2014).”
Identification of blood microRNAs associated to Parkinsońs disease
Margis, R., Margis, R., & Rieder, C. R. M. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.01.023 · Cited by 263
Olivieri, F., Spazzafumo, L., Santini, G., Lazzarini, R., Albertini, M. C., Rippo, M. R., Galeazzi, R., Abbatecola, A. M., Marcheselli, F., Monti, D., et al. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.09.004 · Cited by 248 · cited 4×
“Additionally, miR-146 is known to be involved in regulation of transcripts in two important cellular signaling pathways in cells involved in vascular remodeling: the NFκB and Toll-like receptor pathways (Olivieri et al., 2012).”
InfluentialCirculating miRNAs as Biomarkers for Neurodegenerative Disorders
Grasso, M., Piscopo, P., Confaloni, A., & Denti, M. (2014) · Molecules · doi:10.3390/molecules19056891 · Cited by 208 · cited 1×
“This presents an opportunity to possibly use miRNA screening as a means to detecting pathologies wherein senescence is a factor, such as neurodegenerative diseases, especially given the ease of detection and high specificity of miRNAs (Grasso et al., 2014).”
Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21Waf1/Cip1
Borgdorff, V, Lleonart, M. E., Bishop, C. L., Fessart, D., Bergin, A. H., Overhoff, M. G., & Beach, D. H. (2010) · Oncogene · doi:10.1038/onc.2009.497 · Cited by 160 · cited 2×
“The miR-106b family of miRNAs target the 3’ UTR of the p21 transcript, preventing its translation and function as a tumor suppressor (Borgdorff et al., 2010).”
Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease
Sala Frigerio, C., Lau, P., Salta, E., Tournoy, J., Bossers, K., Vandenberghe, R., Wallin, A., Bjerke, M., Zetterberg, H., Blennow, K., et al. (2013) · Neurology · doi:10.1212/01.wnl.0000437306.37850.22 · Cited by 156 · cited 1×
“In cerebrospinal fluid, decreased expression of hsa-miR-27a-3p was found in Alzheimer’s patients (Sala Frigerio et al., 2013).”
Short Telomeres Compromise β-Cell Signaling and Survival
Guo, N., Parry, E. M., Li, L.-S., Kembou, F., Lauder, N., Hussain, M. A., Berggren, P.-O., & Armanios, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017858 · Cited by 100 · cited 1×
“Additionally, type II diabetes can occur due to excessive telomere shortening in beta pancreatic cells (Guo et al., 2011).”
Guan, J.-Z., Guan, W.-P., Maeda, T., Guoqing, X., GuangZhi, W., & Makino, N. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2274-1 · Cited by 84
Cellular senescence mediated by p16INK4A-coupled miRNA pathways
Overhoff, M. G., Garbe, J. C., Koh, J., Stampfer, M. R., Beach, D. H., & Bishop, C. L. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1096 · Cited by 77 · cited 1×
“Common tumor suppressor systems such as p53, p21, and p16 are regulated by miRNA expression (Borgdorff et al., 2010; Gómez-Cabello et al., 2013; Overhoff et al., 2014; Ugalde et al., 2011; Yamakuchi et al., 2008).”
Sasaki, M., Kajiya, H., Ozeki, S., Okabe, K., & Ikebe, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.123 · Cited by 67
Cited by
Mensà, E., Guescini, M., Giuliani, A., Bacalini, M. G., Ramini, D., Corleone, G., Ferracin, M., Fulgenzi, G., Graciotti, L., Prattichizzo, F., et al. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1725285 · Cited by 187
MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer’s disease
Kumar, S., Vijayan, M., & Reddy, P. H. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx267 · Cited by 167
Self-citationGut microbiome and Alzheimer’s disease: What we know and what remains to be explored
Kapoor, B., Biswas, P., Gulati, M., Rani, P., & Gupta, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102570 · Cited by 46
Regulation of cellular senescence by microRNAs
Ma, X., Zheng, Q., Zhao, G., Yuan, W., & Liu, W. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111264 · Cited by 30
MiRNA-501-3p and miRNA-502-3p: a promising biomarker panel for Alzheimer’s disease
Devara, D., Sharma, B., Goyal, G., Rodarte, D., Kulkarni, A., Tinu, N., Pai, A., & Kumar, S. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70389 · Cited by 22
“26 Many miRNAs have been found to have differential expression in serum and CSF of AD patients, suggesting their possible potential as biomarkers.”
Self-citation
Metadata
- Authors
- Williams, J., Smith, F., Kumar, S., Vijayan, M., & Reddy, P. H.
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 35
- Pages
- 350-363
- ISSN
- 1568-1637 (ISSN-L)
- OpenAlex
- W2555863076
- Cited by
- 101
- References
- 26
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.